Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Zimmer Biomet Holdings, Inc. ZBH

Healthcare  —  Medical Devices
91.04 1.35 1.51% as of 25 Sep
Market cap
$17.1B
P/E
22.0×
S&P 500 Member Dividend Champion (10y) Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Zimmer Biomet Holdings, Inc. (ZBH) EV/EBITDA

As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a EV/EBITDA of 10.6×. Over the past ten years it has ranged from 9.9× (May 2026) to 31.6× (November 2015); the current reading is higher than 4% of that period. That is below the Medical Devices industry median of 11.8× and in line with the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 11.3× (5.10%)
FY2024 11.9× (13.62%)
FY2023 13.8× (17.60%)
FY2022 16.7× (6.51%)
FY2021 17.9× (30.73%)
FY2020 25.8× 52.64%
FY2019 16.9× 20.15%
FY2018 14.1× (9.10%)
FY2017 15.5× (4.59%)
FY2016 16.2× (33.50%)

Quarterly

Period EV/EBITDA Change
Jun 2026 10.2× (5.35%)
Mar 2026 10.8× (4.42%)
Dec 2025 11.3× 3.10%
Sep 2025 10.9× 0.49%
42 more quarters

Against its own ten years

Low 9.9× High 31.6×
Ten-year median 15.9×
Current reading's percentile 4

EV/EBITDA against peers

Company EV/EBITDA
SNN Smith & Nephew SNATS, Inc. compare 5.7×
PHG Koninklijke Philips N.V. compare 8.6×
ZBH Zimmer Biomet Holdings, Inc. 10.6×
GMED Globus Medical, Inc. compare 11.1×
GEHC GE HealthCare Technologies Inc. compare 11.9×
STE STERIS plc compare 13.4×
PEN Penumbra, Inc. compare 58.2×
BIO.B Bio-Rad Laboratories, Inc. compare 176×
BIO Bio-Rad Laboratories, Inc. compare 184×
Medical Devices industry median 11.8×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ZBH